NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.
Publications
Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially pathogenic bacterium in the oral cavity of patients with hematological malignancies
Gut pathogens (2016)
Annals of Clinical Microbiology and Antimicrobials (2015)
Genome announcements (2015)
Genome announcements (2015)
Genome announcements (2015)